Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: results of Phase I/IIa safety and feasibility study
Tanja de Gruijl, Saskia Santegoeds, Sandra van Wetering, Satwinder Kaur Singh, Anthony Hall, Arjan A van de Loosdrecht, Ada Kruisbeek
Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P205; DOI: 10.1186/2051-1426-1-S1-P205
